Live from the NIH registry
Studies recruiting near Akron right now
Top 25 of 394 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (11.5 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
UH Seidman Cancer Center at Southwest General Hospital — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
Premature Birth
N/A
Interventional 203 participants sought
Thrive Neuromedical, LLC — Chagrin Falls, Ohio (25.6 mi)
· Sponsor: Thrive Neuromedical, LLC
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Paramount Med Rsrch and Consult LLC — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Hypochondroplasia
N/A
Observational 400 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: BioMarin Pharmaceutical
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Canton, Ohio (20.8 mi)
· Sponsor: AstraZeneca
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (0.2 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Cleveland Clinic 3 — Warrensville Heights, Ohio (24.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Gabrail Cancer Center — Canton, Ohio (20.8 mi)
· Sponsor: Context Therapeutics Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (20.8 mi)
· Sponsor: Duke University
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UH Minoff Health Center at Chagrin Highlands — Orange, Ohio (25.7 mi)
· Sponsor: Pfizer
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-008 — Canton, Ohio (20.8 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Carcinoma, Non-Small Cell Lung
Phase 1, Phase 2
Interventional 158 participants sought
Gabrail Cancer Center Research — Canton, Ohio (20.8 mi)
· Sponsor: Genprex, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Tri-County Hematology & Oncology Associates, Inc. ( Site 0076) — Massillon, Ohio (19.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: AstraZeneca
CLAiR Pivotal Study
No Condition
N/A
Observational 942 participants sought
Diabetes and Endocrine Associates of Stark County — Canton, Ohio (20.8 mi)
· Sponsor: Toku Eyes Ltd
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Aultman Health Foundation — Canton, Ohio (20.8 mi)
· Sponsor: NRG Oncology
Two Dose Levels of Privigen in Pediatric CIDP
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 4
Interventional 30 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: CSL Behring
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Acute Stroke, Ischemic Stroke
Phase 2, Phase 3
Interventional 728 participants sought
Summa Health Clinical Research Center — Akron, Ohio (0.2 mi)
· Sponsor: DiaMedica Therapeutics Inc
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
Phase 3
Interventional 14 participants sought
Research Site — Highland Hills, Ohio (25.5 mi)
· Sponsor: AstraZeneca
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Primary Mitochondrial Disease
Phase 2
Interventional 180 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: Pharming Technologies B.V.
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Colonic Neoplasms, Neoplasms, Colon
Phase 3
Interventional 892 participants sought
GSK Investigational Site — Akron, Ohio (0.2 mi)
· Sponsor: GlaxoSmithKline
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Diabetes and Endocrinology Associates of Stark County Inc /ID# 256751 — Canton, Ohio (20.8 mi)
· Sponsor: AbbVie